4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-011006
CFO and Treasurer sold 3,035 shares at an average $70.34 ($213,480)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. CFO and Treasurer | 2021-02-11 | Sale | −2,635 | $70.17 | $184,908 | 97,987 | D |
| Krognes Steve E. CFO and Treasurer | 2021-02-11 | Sale | −400 | $71.43 | $28,571 | 97,587 | D |
| Open-market sales · 3,035 sh · avg $70.34 · $213,480 | |||||||
Loading xslF345X03/doc4.xml…